Evidence map›Paper›PMID 31976479›Full record

ArticleHemaSphere2019

MYC Rearranged Aggressive B-Cell Lymphomas: A Report on 100 Patients of the Fondazione Italiana Linfomi (FIL).

Maria Chiara Tisi, Simone Ferrero, Irene Dogliotti, Cristina Tecchio, Giuseppe Carli, Mattia Novo, Piero Maria Stefani, Sara Rattotti, Monica Balzarotti, Dario Marino and 24 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in HemaSphere, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors at 20 institutions in 1 country.

Maria Chiara TisiCell Therapy and Hematology, San Bortolo Hospital, Vicenza, Italy.
Simone FerreroDivision of Hematology 1, Department of Molecular Biotechnologies and Health Sciences, University of Torino/AOU "Città della Salute e della Scienza di Torino", Torino, Italy.
Irene DogliottiDivision of Hematology 1, Department of Molecular Biotechnologies and Health Sciences, University of Torino/AOU "Città della Salute e della Scienza di Torino", Torino, Italy.
Cristina TecchioMedicine, Section of Hematology and Bone Marrow Transplant Unit, University of Verona, Verona, Italy.
Giuseppe CarliCell Therapy and Hematology, San Bortolo Hospital, Vicenza, Italy.
Mattia NovoDivision of Hematology 2, AOU "Città della Salute e della Scienza di Torino", Torino, Italy.
Piero Maria StefaniHEMATOLOGY UNIT Department of Medicine, General Hospital TREVISO, Italy.
Sara RattottiDivision of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Monica BalzarottiHematology Unit, Humanitas Clinical and Research Center - IRCCS - Rozzano/Milano, Italy.
Dario MarinoMedical Oncology 1, Veneto Institute of Oncology IOV IRCCS, Padova, Italy.
Matteo PelosiniClinical and Experimental Medicine, Section of Hematology, University of Pisa, Pisa, Italy.
Alessandra RomanoHematology, AOU Policlinico Vittorio Emanuele, Catania, Italy.
Leonardo FlenghiHematology, O. Santa Maria della Misericordia, Perugia, Italy.
Vittorio Ruggero ZilioliDivision of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Teresa CalimeriLymphoma Unit, Department of Onco-Hematology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Arianna Di NapoliDepartment of Clinical and Molecular Medicine, Roma Sapienza University, Sant'Andrea Hospital, Rome, Italy.
Manuela ZanniHematology, AO SS Antonio e Biagio, Alessandria, Italy.
Erica FinolezziHematology, Transfusional Medicine and Biotechnologies, UOSD "Centro Diagnosi e Terapia dei Linfomi", PO Santo Spirito, Pescara, Italy.
Federico MosnaHEMATOLOGY UNIT Department of Medicine, General Hospital TREVISO, Italy.
Guido GiniHematology Clinic, Department of Clinical and Molecular Sciences, Marche Polytechnic University, Ancona, Italy.
Giovanna MansuetoHematology and Stem Cell Transplantation Unit, IRCCS-CROB, Referral Cancer Center of Basilicata, Rionero in Vulture, PZ, Italy.
Alice Di RoccoCellular Biotechnologies and Hematology, 'Sapienza University', Rome, Italy.
Gabriella TomeiHematology, Ospedale di Ivrea-ASL TO4, Ivrea, Italy.
Nicola SgherzaHematology, IRCCS Ospedale Casa Sollievo Sofferenza, S. G. Rotondo, Italy.
Jacopo OlivieriHematology, Ospedale di Civitanova Marche, Civitanova Marche, Italy.
Luca NassiSCDU Ematologia, AOU Maggiore della Carità, Novara, Italy.
Francesco PiazzaHematology, University of Padova, Padova, Italy.
Angelo FamaHematology, Azienda Unità Sanitaria Locale di Reggio Emilia - IRCCS, Reggio Emilia, Italy.
Antonio GrecoHematology and BM transplant unit A.O.C. Panico Tricase (Le), Italy.
Margherita GiannoccaroHematology, ASL Le/1 P.O. Vito Fazzi, Lecce, Italy.
Anna Maria MazzoneHematology, ASL Taranto, Taranto, Italy.
Carlo ViscoDepartment of Medicine, Section Hematology, University of Verona, Italy.
Giacomo LosetoHematology and Cell Therapy Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Francesco ZajaClinica Ematologica, Centro Trapianti e Terapie Cellulari "Carlo Melzi", Azienda Sanitaria Universitaria Integrata di Udine, Italy.
Ca' Foncello Hospital · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITSapienza University of Rome · ITUniversity of Turin · ITUniversity of Verona · ITAzienda Ospedaliera Citta' della Salute e della Scienza di Torino · ITAzienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo · ITAzienda Ospedaliero Universitaria Maggiore della Carita · ITAzienda Ospedaliero-Universitaria Policlinico - Vittorio Emanuele · ITAzienda Sanitaria Unità Locale di Reggio Emilia · ITAzienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda · ITCasa Sollievo della Sofferenza · ITHumanitas University · ITIstituto di Ricovero e Cura a Carattere Scientifico San RaffaeleIstituto Oncologico Veneto · ITIstituto Tumori Bari · ITL'organizzazione Ospedale di Civitanova M · ITMarche Polytechnic University · ITOspedale Civile Di Ivrea · ITOspedale San Bortolo · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID31976479
PMCPMC6924554
OpenAlexW2988472991

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.